COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform (INHIBIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02196207
Recruitment Status : Withdrawn (The trial was revised to be two protocols, one Prevention, one Eradication Trials.)
First Posted : July 21, 2014
Last Update Posted : August 20, 2019
Information provided by (Responsible Party):
Margaret Ragni, University of Pittsburgh

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : July 2027
Estimated Study Completion Date : July 2027